Tentative Seminar Agenda*

8:00 a.m.	Registration and continental breakfast
9:00 a.m.	Welcome
9:15 a.m.	Competitive Landscape of Biologics: Key Players and Market Forecast Presenter: Ben Duncan
9:45 a.m.	Q&A
10:00 a.m.	Biosimilar ESAs in Europe: What Strategies and Tactics Have Been Taken and What Has Worked? Presenter: Jennifer Robinson
10:30 a.m.	Q&A
10:45 a.m.	Break
11:15 a.m.	Bringing Biosimilar Insulins to Life: New Challengers Emerge to Claim a Piece of the $14 Billion Insulin Market Presenter: Donny Wong, Ph.D.
11:45 p.m.	Q&A
Noon	Lunch
1:15 p.m.	Rituximab: Paving the Way for Therapeutic Biosimilar Monoclonal Antibodies in Oncology Presenter: Andrew Merron, Ph.D.
1:45 p.m.	Q&A
2:00 p.m.	Biologics in Breast Cancer – What Threatens Herceptin’s Dominance? Presenter: Niamh Buckley, Ph.D.
2:30 p.m.	Q&A
2:45 p.m.	Break
3:15 p.m.	Market Access for Biologics—An Increasingly Challenging Obstacle Course Presenter: Neil Grubert, M.A.
3:45 p.m.	Q&A
4:00 p.m.	How Will Cost-Cutting Hurdles Impact Speed and Breadth of Uptake of Biologics Across the EU5; A Focus on Crohn’s Disease and Ulcerative Colitis Presenter: Janie Cox, Ph.D.
4:30 p.m.	Q&A
4:45 p.m.	Closing remarks and reception

*Agenda and timing are subject to change.

THURSDAY, 16 June 2011
8:00 a.m. - 7:00 p.m.

THE LANDMARK LONDON
222 Marylebone Road
London, United Kingdom
+44 (0) 20 7631 8000
www.landmarklondon.co.uk